TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to pharmacy, Medicare Part D, and prescription drug pricing policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Health Issues HCR
Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability. Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Defense DEF
Pharmacy issues related to TRICARE.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.